@article{TCR16925,
author = {Yasuhiko Sugawara},
title = {Living-donor liver transplantation for hepatocellular carcinoma in Japan and Korea},
journal = {Translational Cancer Research},
volume = {6},
number = {Suppl 9},
year = {2017},
keywords = {},
abstract = {Liver transplantation is now one of established therapeutic options for patients with hepatocellular carcinoma (HCC) and decompensated cirrhosis (1). Liver transplantation is a theoretically ideal therapeutic modality because both the tumor and the underlying disease of the liver can be treated at the same time (2).},
issn = {2219-6803}, url = {https://tcr.amegroups.org/article/view/16925}
}